loading
Precedente Chiudi:
$11.50
Aprire:
$11.58
Volume 24 ore:
1.57M
Relative Volume:
0.26
Capitalizzazione di mercato:
$7.74B
Reddito:
$125.68M
Utile/perdita netta:
$4.81B
Rapporto P/E:
2.0159
EPS:
5.65
Flusso di cassa netto:
$-781.21M
1 W Prestazione:
-0.91%
1M Prestazione:
-0.57%
6M Prestazione:
+2.01%
1 anno Prestazione:
+3.86%
Intervallo 1D:
Value
$11.38
$11.64
Intervallo di 1 settimana:
Value
$11.38
$11.74
Portata 52W:
Value
$8.73
$13.05

Roivant Sciences Ltd Stock (ROIV) Company Profile

Name
Nome
Roivant Sciences Ltd
Name
Telefono
441-295-5950
Name
Indirizzo
7TH FLOOR, 50 BROADWAY, LONDON
Name
Dipendente
750
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-10
Name
Ultimi documenti SEC
Name
ROIV's Discussions on Twitter

Confronta ROIV con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ROIV
Roivant Sciences Ltd
11.38 7.72B 125.68M 4.81B -781.21M 5.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.85 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
574.13 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.25 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
569.71 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.85 29.19B 3.81B -644.79M -669.77M -6.24

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-10 Ripresa Goldman Buy
2024-02-15 Iniziato Wolfe Research Outperform
2024-01-05 Iniziato Piper Sandler Overweight
2023-12-12 Iniziato Deutsche Bank Buy
2023-10-17 Iniziato Guggenheim Buy
2023-06-08 Iniziato BofA Securities Neutral
2022-10-27 Iniziato JP Morgan Overweight
2022-05-23 Iniziato SVB Leerink Outperform
2022-04-29 Iniziato Cantor Fitzgerald Overweight
2021-12-15 Iniziato Goldman Buy
2021-11-08 Iniziato H.C. Wainwright Buy
2021-10-28 Iniziato Citigroup Buy
2021-10-26 Iniziato Cowen Outperform
2021-10-26 Iniziato Jefferies Buy
2021-10-26 Iniziato Truist Buy
Mostra tutto

Roivant Sciences Ltd Borsa (ROIV) Ultime notizie

pulisher
10:41 AM

What drives Roivant Sciences Ltd. stock priceExceptional risk-adjusted gains - jammulinksnews.com

10:41 AM
pulisher
01:43 AM

What analysts say about Roivant Sciences Ltd. stockTriple-digit profit margins - jammulinksnews.com

01:43 AM
pulisher
Jul 22, 2025

Roivant Sciences Ltd. Stock Analysis and ForecastAccelerated wealth building - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Is Roivant Sciences Ltd. a good long term investmentFree Stock Selection - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

(ROIV) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 18, 2025
pulisher
Jul 10, 2025

Goldman Sachs resumes Roivant Sciences stock coverage with Buy rating By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Goldman Sachs resumes Roivant Sciences stock coverage with Buy rating - Investing.com India

Jul 10, 2025
pulisher
Jul 07, 2025

How to Take Advantage of moves in (ROIV) - news.stocktradersdaily.com

Jul 07, 2025
pulisher
Jul 05, 2025

Roivant Sciences: Booming Pipeline Without Product Revenues Creates Valuation Riddle - Seeking Alpha

Jul 05, 2025
pulisher
Jun 26, 2025

'Just the beginning': Vivek Ramaswamy breaks record in raising fund for Guv election campaign, $8.5 milli - Times of India

Jun 26, 2025
pulisher
Jun 25, 2025

Hedge Fund and Insider Trading News: Ken Griffin, Warren Buffett, Michael Burry, AQR Capital Management, Tiger Global Management, Amplify Energy Corp (AMPY), Roivant Sciences ltd (ROIV), and More - Insider Monkey

Jun 25, 2025
pulisher
Jun 24, 2025

Roivant Sciences Announces $500M Share Repurchase Program - TipRanks

Jun 24, 2025
pulisher
Jun 23, 2025

Roivant Sciences (ROIV): Ramaswamy sells $13 million in shares - Investing.com

Jun 23, 2025
pulisher
Jun 18, 2025

HC Wainwright & Co. Reiterates Buy Rating for Roivant Sciences (ROIV) | ROIV Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Cantor Fitzgerald reiterates overweight rating on Roivant Sciences stock By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

H.C. Wainwright reiterates buy rating on Roivant Sciences stock By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Guggenheim maintains buy rating on Roivant Sciences stock amid DM study - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

JPMorgan Maintains Positive Outlook on Roivant Sciences (ROIV) | ROIV Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 17, 2025

Roivant (ROIV) Hosts Investor Webinar on Brepocitinib's Role in Dermatomyositis | ROIV Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Long Term Trading Analysis for (ROIV) - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 16, 2025

Roivant (ROIV) Publishes Promising Phase 1 Results for Inhaled M - GuruFocus

Jun 16, 2025
pulisher
Jun 10, 2025

Roivant Sciences at Goldman Sachs Conference: Strategic Execution Focus By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Roivant Sciences at Goldman Sachs Conference: Strategic Execution Focus - Investing.com Australia

Jun 10, 2025
pulisher
Jun 09, 2025

Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in Dermatomyositis - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Rare Disease Breakthrough: Roivant Reveals Brepocitinib Data for Dermatomyositis Treatment - Stock Titan

Jun 09, 2025
pulisher
Jun 07, 2025

Major Shareholder Cashes Out Millions in Roivant Sciences Stock - TipRanks

Jun 07, 2025
pulisher
Jun 04, 2025

(ROIV) Trading Advice - news.stocktradersdaily.com

Jun 04, 2025
pulisher
May 31, 2025

Vivek Ramaswamy’s firm wants to buy biotech companies to bet on bitcoin - MSN

May 31, 2025
pulisher
May 31, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $324,000 Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - Defense World

May 31, 2025
pulisher
May 31, 2025

Roivant Sciences Earnings Call: Balancing Growth and Challenges - MSN

May 31, 2025
pulisher
May 30, 2025

Roivant outlines packed 36-month launch and data cycle with under $5B cash reserve and multi-blockbuster pipeline - MSN

May 30, 2025
pulisher
May 30, 2025

Decoding Roivant Sciences Ltd (ROIV): A Strategic SWOT Insight - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2024 Earnings Call Transcript - Insider Monkey

May 30, 2025
pulisher
May 30, 2025

Roivant Sciences Full Year 2025 Earnings: EPS Beats Expectations, Revenues Lag - simplywall.st

May 30, 2025
pulisher
May 30, 2025

While Wall Street Naps, These 10 Stocks Run Wild - Insider Monkey

May 30, 2025
pulisher
May 30, 2025

Why Roivant Sciences Ltd. (ROIV) Surged On Thursday - Insider Monkey

May 30, 2025
pulisher
May 30, 2025

Roivant Sciences Ltd (ROIV) Q4 2024 Earnings Call Highlights: Strong Financial Position and ... By GuruFocus - Investing.com Canada

May 30, 2025
pulisher
May 30, 2025

Roivant Sciences Reports Progress and Financial Results - TipRanks

May 30, 2025
pulisher
May 29, 2025

IMVT INVESTIGATION ALERT: Investigation Launched into Private Placement Transaction by Immunovant, Inc. and Attorneys Encourage Investors to Contact Law Firm - The Malaysian Reserve

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates - MSN

May 29, 2025
pulisher
May 29, 2025

IMVT INVESTIGATION ALERT: Investigation Launched into Private Placement Transaction by Immunovant, Inc. and Attorneys Encourage Investors to Contact Law Firm – Company AnnouncementFT.com - Financial Times

May 29, 2025
pulisher
May 29, 2025

ROIV Crosses Above Key Moving Average Level - Nasdaq

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences earnings missed by $0.03, revenue fell short of estimates - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences Q4 2025 Earnings Call Transcript - MarketBeat

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences (ROIV) Stock Jumps Nearly 5%: What’s Fueling This Biotech Rally? - Daily Chhattisgarh News

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 - marketscreener.com

May 29, 2025

Roivant Sciences Ltd Azioni (ROIV) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Roivant Sciences Ltd Azioni (ROIV) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Venker Eric
President & COO
Jun 20 '25
Option Exercise
3.85
100,000
385,000
1,562,223
Venker Eric
President & COO
Jun 20 '25
Sale
11.45
100,000
1,145,000
1,462,223
Ramaswamy Vivek
10% Owner
Jun 20 '25
Sale
11.46
577,007
6,612,500
37,284,108
Ramaswamy Vivek
10% Owner
Jun 18 '25
Sale
11.45
565,266
6,472,296
37,861,115
$22.89
price up icon 5.00%
$35.97
price down icon 0.42%
$102.81
price down icon 0.20%
$27.68
price up icon 4.45%
$113.60
price up icon 1.92%
biotechnology ONC
$295.07
price down icon 0.16%
Capitalizzazione:     |  Volume (24 ore):